NEW YORK, Sept. 2, 2026 /PRNewswire/ — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Geron Corporation (NASDAQ: GERN) breached their fiduciary duties to shareholders.
According to a federal securities lawsuit, Geron Corporation misrepresented or failed to disclose the true state of its sole commercial product, Rytelo, including that: (1) Rytelo’s commercial launch was plagued by open conflict between the Company’s medical and commercial teams; (2) the Company’s sales force was sent into the market without any marketing materials beyond the bare FDA prescribing information; (3) the Company had failed to educate its primary target market – community physicians – about Rytelo; and (4) that as a result, Rytelo’s growth and revenue had flattened only weeks after its launch.
If you currently own GERN and purchased prior to February 28, 2024 please contact Sophia Anne Silayan by email at sophiaanne@kuehn.law or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
For additional information, please visit Shareholder Derivative Litigation – Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-geron-corporation-to-contact-law-firm-302867864.html
SOURCE Kuehn Law, PLLC
